OPTINOSE INC. - COMMO
0.5395
29-十一月-24 11:37:03
15 分钟延时
股票
+0.0038
+0.71%
今日范围
0.4600 - 0.5655
ISIN
N/A
来源
NASDAQ
-
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
22 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
Optinose Reports Third Quarter 2023 Financial Results and Operational Updates
09 11月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Optinose Announces Reporting Date for Third Quarter 2023 Financial Results
27 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Optinose to Present at the 2023 Cantor Global Healthcare Conference
22 9月 2023 08:01:00 条件 Nasdaq GlobeNewswire
-
Optinose Reports Second Quarter 2023 Financial Results and Operational Updates
10 8月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million
27 7月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
16 6月 2023 15:08:00 条件 Nasdaq GlobeNewswire
-
Optinose to Present at the Jefferies Healthcare Conference
02 6月 2023 12:00:00 条件 Nasdaq GlobeNewswire
-
Optinose Reports First Quarter 2023 Financial Results and Operational Updates
11 5月 2023 06:00:18 条件 Nasdaq GlobeNewswire
-
Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE
04 5月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
Optinose Announces Reporting Date for First Quarter 2023 Financial Results
01 5月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
18 4月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Optinose to Present at the Needham Virtual Healthcare Conference
12 4月 2023 15:00:00 条件 Nasdaq GlobeNewswire
-
07 3月 2023 06:00:56 条件 Nasdaq GlobeNewswire
-
Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results
28 2月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion
21 2月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
Optinose Announces CEO Transition and Business Update
31 1月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
Optinose Appoints Paul Spence as Chief Commercial Officer
15 12月 2022 15:30:00 条件 Nasdaq GlobeNewswire
-
Optinose Announces Departure of Acting Chief Financial Officer
09 12月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
30 11月 2022 06:00:00 条件 Nasdaq GlobeNewswire